A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

NCT07464314 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human+COVID-19

Interventions

BIOLOGICAL: Investigational mRNA Seasonal Flu/COVID-19 Combination (Flu/COVm) Vaccine
BIOLOGICAL: Licensed Seasonal Influenza Vaccine
BIOLOGICAL: Licensed COVID-19 Vaccine

Sponsor

GlaxoSmithKline